Post Resch Tallon Group Inc.
- SEC CIK
- 0002054476
- Latest filing
- Jul 7, 2026
SNDX holding history
Syndax Pharmaceuticals Inc in every 13F filed by Post Resch Tallon Group Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SNDX overviewAll 13F holders of SNDXFull Q2 2026 holdings
- Shares (Q2 2026)
- 12,500
- Value
- $273.3K
- % of portfolio
- 0.2%
- Quarters held
- 4
- Since Q3 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 12,500 | $273.3K | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2026 | 12,500 | $302.4K | 0.2% | −10,300−45.2% | Reduced | Holders |
| Q4 2025 | 22,800 | $479.0K | 0.4% | −3,000−11.6% | Reduced | Holders |
| Q3 2025 | 25,800 | $396.9K | 0.4% | +25,800 | New | Holders |